Btg Plc (BTGGF) Expected to Post FY2019 Earnings of $0.48 Per Share

Btg Plc (OTCMKTS:BTGGF) – Research analysts at Jefferies Group issued their FY2019 EPS estimates for shares of BTG in a note issued to investors on Wednesday, May 16th. Jefferies Group analyst P. Welford anticipates that the company will earn $0.48 per share for the year. Jefferies Group also issued estimates for BTG’s FY2020 earnings at $0.50 EPS, FY2021 earnings at $0.61 EPS and FY2022 earnings at $0.75 EPS.

Separately, Zacks Investment Research lowered BTG from a “buy” rating to a “hold” rating in a research report on Thursday, March 29th.

Shares of BTG opened at $8.50 on Friday, according to Marketbeat.com. BTG has a 52 week low of $8.06 and a 52 week high of $10.88.

About BTG

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, Asia, and internationally. It operates through three segments: Interventional Medicine, Specialty Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.

Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply